Trials / Terminated
TerminatedNCT03010423
Efficacy Study of Oral Nicorandil on Improving Microvascular Function in Female Non-obstructive Coronary Artery Disease (CAD) Participants
An Interventional, Pilot Study to Evaluate the Efficacy of Oral Nicorandil on Improving Microvascular Function in Female Non-obstructive CAD Patients (SPET Study)
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Merck KGaA, Darmstadt, Germany · Industry
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The study is a single-center, interventional, pilot study to evaluate the improvement of microvascular function by positron emission tomography (PET) after twelve-week treatment of oral nicorandil in female non-obstructive CAD Participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nicorandil | Participants received Nicorandil 5 milligram (mg) tablet, three times a day for 12 weeks. |
Timeline
- Start date
- 2016-11-30
- Primary completion
- 2019-07-09
- Completion
- 2019-07-09
- First posted
- 2017-01-05
- Last updated
- 2020-07-07
- Results posted
- 2020-07-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03010423. Inclusion in this directory is not an endorsement.